Quick Dispatch:
Your semaglutide discontinuation study denmark 2025 september Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications | BMC Medicine orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your semaglutide discontinuation study denmark 2025 september Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications | BMC Medicine ships.
Need Help?
Questions about semaglutide discontinuation study denmark 2025 september Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications | BMC Medicine, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for semaglutide discontinuation study denmark 2025 september Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications | BMC Medicine in your area.
ISPOR 2025: Exploring reasons for GLP-1 discontinuation
26.73
Quarterly incidence rate of new users (A) and quarterly total user
26.88
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults
28.92
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
22.43
How Long Has Semaglutide Been Studied? Research Timeline
20.64
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
21.22
Long-term comparative effectiveness of once-weekly semaglutide versus alternative treatments in a real-world US adult population with type 2 diabetes: a randomized pragmatic clinical trial
20.20
